Recruiting Clinical Trials

Displaying 1 - 10 of 34 result(s)
Study Title Condition Phase Location
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With TQJ230 on Major Cardiovascular Events in Patients With Established Cardiovascular Disease Cardiovascular Disease and Lipoprotein(a) Phase 3
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Australia
  • Country: 
A Phase II, Open Label, Randomized, Parallel Arm Study of NIS793 (With and Without Spartalizumab) in Combination With SOC Chemotherapy Gemcitabine/Nab-paclitaxel, and Gemcitabine/Nab-paclitaxel Alone in First-line Metastatic Pancreatic Ductal Adenoca ... Metastatic Pancreatic Ductal Adenocarcinoma Phase 2
  • Country: 
    United States
  • Country: 
    Australia
  • Country: 
    Austria
  • Country: 
A Randomized, Multicenter, Active-comparator Controlled, Open-label Trial to Evaluate Efficacy and Safety of Oral, Twice Daily LNP023 in Adult Patients With PNH and Residual Anemia, Despite Treatment With an Intravenous Anti-C5 Antibody. Paroxysmal Nocturnal Hemoglobinuria (PNH) Phase 3
  • Country: 
    United States
  • Country: 
    Brazil
  • Country: 
    Czech Republic
  • Country: 
A Randomized, Subject and Investigator Blinded, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis Atopic Dermatitis Phase 2
  • Country: 
    Czech Republic
  • Country: 
    Germany
  • Country: 
    Hungary
  • Country: 
A Randomized, Multi-center, Subject and Investigator-blinded, Placebo-controlled, Parallel-group Study to Assess the Efficacy Safety and Tolerability of LYS006 in Patients With Mild to Moderate Ulcerative Colitis Colitis, Ulcerative Phase 2
  • Country: 
    Bulgaria
  • Country: 
    Czech Republic
  • Country: 
    Germany
  • Country: 
PSMAfore: A Phase III, Open-label, Multi-Center, Randomized Study Comparing 177Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in the Treatment of Taxane Naïve Men With Progressive Metastatic Castrate Resistant Prostate Cancer Prostatic Neoplasms Phase 3
  • Country: 
    United States
  • Country: 
    Austria
  • Country: 
    Czech Republic
  • Country: 
A Randomized, Double-blind, Placebo-controlled Phase III Multi-center Study of Azacitidine With or Without MBG453 for the Treatment of Patients With Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS) as Per IPSS-R, or Chronic Myelomo ... Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic Phase 3
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Australia
  • Country: 
The Multi-National Gilenya Pregnancy Exposure Registry in Multiple Sclerosis Multiple Sclerosis Not Given
  • Country: 
    United States
  • Country: 
    Argentina
  • Country: 
    Australia
  • Country: 
A Randomized, Subject and Investigator Blinded, Placebo Controlled, Multi-center Study in Parallel Groups to Assess the Efficacy and Safety of LYS006 in Patients With Moderate to Severe Inflammatory Acne Inflammatory Acne Phase 2
  • Country: 
    United States
  • Country: 
    Czech Republic
  • Country: 
    France
  • Country: 
A Subject and Investigator Blinded, Randomized, Placebo-controlled, Repeat-dose, Multicenter Study to Investigate Efficacy, Safety, and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis Pulmonary Sarcoidosis Phase 2
  • Country: 
    United States
  • Country: 
    Czech Republic
  • Country: 
    Denmark
  • Country: